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Abstract
Menopause is a period that may predispose one to a decrease in muscle strength, cardiore-
spiratory fitness, and quality of life. A study was carried out to evaluate the cost-effective-
ness of physical activity among women displaying symptoms of menopause. The cost-
effectiveness analysis was based on data from a six-month randomised controlled trial (n =
151). The women in the intervention group engaged in an unsupervised session of at least
50 minutes of physical activity four times a week. The control group continued their physical
activity as before. An incremental cost-effectiveness ratio (ICER) was calculated in terms of
maximal oxygen consumption, lean muscle mass, and quality-adjusted life years (QALYs)
gained. A bootstrap technique was utilised to estimate uncertainty around the point estimate
for ICER associated with the intervention. The mean total cost in the intervention group was
€1,307 (SEM: €311) and in the control group was €1,253 (SEM: €279, p = 0.10) per person.
The mean intervention cost was €208 per person. After six months of the behaviour-change
intervention, the ICER was €63 for a 1 ml/kg/min improvement in cardiorespiratory fitness,
the additional cost per one-gram increase in lean muscle mass was €126, and the cost per
QALY gained was €46. According to the findings, physical activity among menopausal
women was cost-effective for cardiorespiratory fitness, for lean muscle mass, and for
QALYs gained, since the intervention was more effective than the actions within the control
group and the additional effects of physical activity were gained at a very low price. From
the societal perspective, the intervention used may promote ability to work and thereby
save on further costs associated with early retirement or disability pension if the physical-
activity level remains at least the same as during the intervention.
Introduction
Menopause, the time in a woman’s life that leads to the end of fertility [1], occurs internation-
ally at, on average, age 45 to 52 [2]. During menopause, the decreasing amount of various hor-
mones and steroids, such as oestrogen and progesterone, may cause depression and anxiety but
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also vasomotor symptoms, including hot flushes [1, 3]. In addition, hormonal reduction speeds
up ageing while also increasing the risk of chronic diseases such as osteoporosis and cardiovas-
cular disease, on account of elevated triglycerides, LDL cholesterol, and total cholesterol [1, 3].
Menopause is also a period that may predispose one to a decrease in health-related quality of
life (HRQoL) and muscle strength while increasing body mass index (BMI) [1, 3].
According to global physical-activity recommendations, adults should engage in, at mini-
mum, 150 minutes of at least moderate-intensity physical activity a week, with the suggested
approach being sessions of 10 minutes duration or more, at least three times per week [4].
Though a physically active lifestyle has been shown to have an important role in health, 26% of
women at menopausal age (45 to 64 years) did not meet the physical-activity recommendation
for cardiorespiratory fitness in Finland, on average [5]. Internationally the prevalence of physi-
cal inactivity was even greater, since in Americas and the eastern Mediterranean region around
45% of women of menopausal age (45 to 59 years), and in Europe overall 37%, did not meet
the physical-activity recommendation [6].
Physical activity of at least moderate intensity has been shown to prevent cardiovascular dis-
ease among menopausal women because of improved blood lipids and may also decrease body
fat, thereby reducing a risk factor for diabetes [7]. Moreover, physical activity may reduce men-
opause symptoms such as hot flushes and thereby improve quality of life [8, 9]. Even though
menopause is a phenomenon that concerns all women to some extent, no cost-effectiveness
studies related to physical activity and menopausal women without hormone therapy had been
done prior to the work described here. The topic is important from a societal perspective
because regular physical activity of at least moderate intensity may help women of menopausal
age to maintain their capacity for work, via improved cardiorespiratory fitness and muscle
strength, both of which gradually decrease after age 40–50 [10]. It is of societal relevance that
decreased capacity for work may leave one prone to early retirement and to disability pension.
In addition, physical activity may help to keep health-care costs under control by preventing
symptoms and disorders related to menopause.
We have earlier published the main results from our randomised trial (RCT) among meno-
pausal women. The aim of that RCT was to estimate whether aerobic training had an effect on
frequency of hot flushes or quality of life [9]. Results of the study showed that HRQoL was
improved among the intervention group with respect to physical functioning (p = 0.049) and
physical role limitation (p = 0.017). Cardiorespiratory fitness improved in the intervention
group from 31.7 to 32.6 ml/kg/min and decreased in the control group from 31.5 to 31.4 ml/
kg/min (p = 0.008), and lean muscle mass rose significantly in the intervention group relative
to controls (0.57 kg in contrast to 0.15 kg, p = 0.046) [8]. The aim of the study reported upon
here was to assess the cost-effectiveness of at least moderate-intensity physical activity for
cardiorespiratory fitness, for lean muscle mass, and per quality-adjusted life year (QALY)
gained among menopausal women.
Material and Methods
Study design and participants
The cost-effectiveness analysis was based on a randomised controlled trial (n = 151), the main
objective of which was to evaluate the effect of unsupervised physical activity on hot flushes
and quality of life among menopausal women (trial registration ISRCTN54690027; see http://
www.controlled-trials.com/) [9, 11]. Participants were enrolled via newspaper advertisements
between January and March 2009 in Finland. The duration of the cost-effectiveness trial was
six months, so it represented only a half-year follow-up. The study was approved by the medi-
cal ethics committees of the Pirkanmaa hospital district, and participants’ informed consent
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was obtained with a signature at the first appointment. The research was conducted in accor-
dance with prevailing ethics principles. Collection of data for the economic evaluation was per-
formed during the original RCT study.
The inclusion criteria were daily hot flushes, an age of 40–63, neither current hormone ther-
apy nor use of it within the previous three months, a sedentary lifestyle (physical activity no
more than twice a week), and 6–36 months since last menses. Women who were physically
active (defined as engaging in at least 30 minutes of vigorous physical activity at least three
times a week), were obese (BMI> 35 kg/m²), or had a physical condition preventing physical
activity (cardiorespiratory or orthopaedic disease or a medication influencing heart rate, such
as beta-blockers) were excluded.
Outcome measurements
The cost-effectiveness of the intervention was evaluated in terms of cardiorespiratory fitness
(VO2Max), lean muscle mass (kg), and QALYs gained. Cardiorespiratory fitness was evaluated
by means of the UKK two-kilometre walk test [12] at the beginning and end of the trial. In its
consideration of lean muscle mass, the cost-effectiveness analysis measured it via dual x-ray
absorptiometry (DXA) at the start and the end of the trial. The QALY data were calculated
from the SF-6D score derived from the original SF-36 data, which is a validated instrument for
measuring the physical and mental components of quality of life [13–15]. The index score cov-
ers eight dimensions of HRQoL: physical functioning, physical role limitation, bodily pain,
general health, vitality, social functioning, emotional role limitation, and mental health. The
index score is expressed by a single number, from 0 (representing the death) to 1 (denoting the
best health state). To calculate QALYs gained, after the difference in index score between six
months and the baseline was taken into account, the index was multiplied by the expected life-
time calculated for each woman separately. The weighting of the index score was based on the
UK population [13]. The HRQoL data were collected via questionnaires completed at the
beginning and at the end of the six-month trial. Even though the frequency of hot flushes and
responses to a women’s health questionnaire (WHQ) were used as outcomes in the original
study, they were not employed as outcomes in the cost-effectiveness analysis, because the
results could not be presented by means of one index number.
The intervention group
The participants in the training group (n = 74) were instructed to engage in four unsupervised
sessions of physical activity per week, of at least 50 minutes’ duration each. At least two physi-
cal-activity sessions were to consist of walking or Nordic walking, which is walking with poles
that are intended to increase the efficiency of the exercise. Walking was chosen as a mode of
physical activity because of earlier demonstration of favourable effects of walking on meno-
pausal women’s body composition and cardiorespiratory fitness [7]. To achieve at least moder-
ate-intensity physical activity, the women were instructed to exercise at a subjective level of
‘somewhat hard’ (corresponding to 13–16 on a 6–20 scale) [16], which is consistent with the
intensity of aerobic training recommended in physical-activity guidelines [4]. The required
subjective intensity corresponded to about 64–80% of maximal heart rate [16].
For obtaining objective data on intensity of physical activity, the intervention group wore
heart-rate monitor belts by Suunto during the training sessions. These collected data on both
the intensity and the duration of the sessions. To ensure collection of data on physical activity,
the heart-rate monitor belts were complemented with gathering of information via a question-
naire on physical activity during the intervention. The physical-activity questionnaire included
items on the type of physical activity, minutes of activity, and its intensity. For sustained
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commitment to the trial, the members of the intervention group received feedback on compari-
son to recommendations from an aerobic training instructor, every second week. The personal
feedback given every other week concentrated on intensity and amount of training in compari-
son to the recommendations but also on motivation to continue the physical activity in spite of
physical discomfort or symptoms of menopause, which are commonplace among physically
inactive women [1]. The aerobic training instructor took advantage of information from the
heart-rate belts in order to increase the effectiveness of participants’ physical activity progres-
sively from 64% (at the beginning of the intervention) to 80% of maximal heart rate (at the end
of the intervention).
In addition, the women in the intervention group were offered an opportunity to take part
in instructor-led aerobics sessions twice a week. Participants in both groups were given per-
sonal mobile phones to report information on the intensity of their hot flushes, which was the
main outcome in the original intervention. Moreover, the intervention and control group both
took part in, on average, twice-monthly lectures that covered topics related to physical activity
and women’s health. In the course of the six months, there were 14 dropouts (representing
9.3% of the sample) from the intervention group.
The control group
The women in the control group (n = 77) were advised to continue their physical activity as
before. However, these participants were encouraged to take part in the same twice-monthly
lectures as those in the intervention group. To control for maintenance of physical activity, a
questionnaire was used to ask women in the control group about their physical-activity habits
over the past three months at both the beginning and the end of the intervention. The number
of persons who dropped out from the control group was eight (5.3% of the total). In addition,
three persons’ data were excluded from analysis for reason of missing data.
Economic evaluation
The economic evaluation included intervention costs, health-care costs for the municipality,
costs borne by the patient, and productivity costs from the societal perspective. The travel
expenses and time costs related to the use of health services should have featured in the calcula-
tion, but this information was not available. The opportunity cost, which in economics denotes
the value of the best alternative forgone, was not estimated, because there was no precise infor-
mation available on the time spent engaging in physical activity during the intervention period
by the control group.
The information on the use of health-care services (visits to physicians and to nurses,
including occupational health nurses), inpatient days, and medication was obtained via ques-
tionnaires at the beginning and at the end of the trial. Medications received on inpatient days
were not included in the ‘medication costs’ category, because they were already covered by
daily inpatient costs [17]. The medication cost includes both the patient- and the society-borne
amount; the 2009 medication costs were 42% covered by the patient, with society contributing
the rest of the amount [18]. Health-care costs were calculated from the average national unit
costs for health care [17]. The unit costs of visits to physicians and to nurses included salary
costs and administrative costs but not laboratory expenses. In addition, the unit cost of inpa-
tient hospital days included the daily inpatient-care charge [17]. Costs were calculated for the
full six-month physical-activity trial period. Unit costs, productivity costs, and medication
costs were entered at 2009 price levels in euros.
The intervention costs were obtained directly from the trial and included the cost of the
work contribution of the aerobic training instructor and the physicians’ contribution. The
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work contribution of the aerobic training instructor consisted of leading one-hour aerobic
training sessions twice a week and giving personal feedback every second week on the heart-
rate belt data with regard to realisation of physical activity. The cost of the mobile phones and
of the heart-rate belts were also included in the intervention costs. The physicians’ work contri-
bution consisted of implementation of lectures related to women’s health, and salary expenses.
Lost productivity was evaluated by means of self-reported information on absence from
part- or full-time work via a questionnaire at the end of the trial. Salary costs were calculated
from women’s average national monthly salary scales in 2009 [19], multiplied by 1.3 so as to
encompass related expenses. The cost calculation assumed 220 workdays a year.
Statistical analysis
Baseline characteristics, costs, and effects were reported as means and standard error of mean
(SEM) values or as frequencies and percentages. The association between the groups was tested
with the Mann-Whitney U test. In the case of some data related to results for cardiorespiratory
fitness, lean muscle mass, and the SF-36 questionnaire, imputations for missing values were
performed via multiple imputation technique via the Stata software (with the mi command).
Cost data were available for all participants. For evaluation of cost-effectiveness, the differences
between groups were analysed via a non-parametric bootstrap approach. Cost-effectiveness
was expressed in terms of incremental cost-effectiveness ratios (ICERs), which indicate the
amount of money that is required to increase cardiorespiratory fitness, lean muscle mass, and
QALYs gained. Health-related quality of life was judged on the basis of the standardised SF-36
questionnaire, which refers to 36 physical and mental components of everyday life during the
past four weeks [13–15]. A bootstrap technique with 5,000 replications [20] and cost-effective-
ness acceptability curves were used to assess 95% confidence intervals for purposes of analysing
the uncertainty around the point estimate of the ICER. The formula for calculation of ICER is
ICER ¼ ðCostIntervention  CostControlÞ=ðEffectInterventionEffectControlÞ:
The confidence intervals (CIs) were calculated by means of a bias-corrected and accelerated
(BCa) method proposed by Efron [21]. The BCa interval is given in terms of percentiles of the
bootstrap distribution of differences in means, but the percentiles used are chosen after correc-
tion for skewness or ‘acceleration’ â and bias [22]. The results were considered to be statistically
significant if p< 0.05. Analyses were performed with SPSS (version 22) and Stata (version
12.1) statistics software.
Sensitivity analysis
To evaluate the robustness of the findings, we performed sensitivity analysis in three separate
ways. Firstly, aerobic training instructors’ costs as a component of the intervention costs were
doubled. The reason for doubling the value of aerobic training instructor costs per person was
the brevity of the counselling sessions realised: there was only 16 minutes per person, every sec-
ond week. For women with menopause symptoms, twice the amount of time (32 minutes) was
more realistic. Secondly, we carried out sensitivity analysis with equal mobile-phone and heart-
monitor costs across the two groups. For greater reliability of the results, all measurements per-
formed for the intervention and control group should have been the same between the groups.
The third sensitivity analysis was a complete case analysis. This entailed including only those
participants whose data were available in full, without imputation, with respect to cardiorespi-
ratory fitness, lean muscle mass, and the SF-36 questionnaire.
Cost-Effectiveness of Physical Activity during Menopause
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Results
Of the 151 women with menopause symptoms, 74 (49%) were in the intervention group and
77 (51%) were in the control group (see Table 1).
Costs
The per-person mean total cost was nearly the same between the intervention and the control
group (at €1,307 and €1,253, respectively; p = 0.10); see Table 2. The direct costs and productiv-
ity costs were nine per cent lower in the intervention group than for the control group (€1,100
and €1,208, respectively; p = 0.53). The mean cost per person during the intervention was
€208, which was 16% of the total costs for the intervention group. There were no statistically
significant differences between the intervention and control group in direct costs (visits to a
physician or to a nurse, medication, and days of inpatient care) or absence from work (see the
costs detailed in Table 2). The largest proportion of the intervention costs consisted of the aero-
bic-training work contribution, which came to 3.5 hours per participant over the six months
(see Table 2).
Cost-effectiveness
The difference between cost values relative to maximal oxygen consumption was €54 (95% CI:
-€740 to €914) and for effects relative to maximal oxygen consumption 0.86 ml/kg/min (95%
CI: 0.15 to 1.60). The ICER was €63 for maximal oxygen consumption (see Table 3). As the
cost-effectiveness plane indicates (see Fig 1), the intervention in VO2Max terms was more
effective but there were no statistically significant differences in costs in comparison to the con-
trol group. Thus the data show that a one-unit improvement in cardiorespiratory fitness mea-
sured in ml/kg/min requires an additional cost of €63 per person. The second ICER was €126
per unit lean muscle mass, which represents a requirement for €126 additional cost for a one-
gram increase in lean muscle mass in menopausal women. The final ICER was €46 per QALY
gained (see Table 3). The cost-effectiveness acceptability curves indicate the probability of cost-
effectiveness for various threshold values (see Fig 2). There is a 95% probability that the inter-
vention would be cost-effective if society were willing to pay €1,398 per one-point
Table 1. Baseline characteristics (mean and standard error of mean or frequency and proportion).
Intervention group
(n = 74)
Control group
(n = 77)
Age 54.5 (0.44) 54.2 (0.43)
Weight (kg) 70.5 (1.32) 71.7 (1.43)
BMI (kg/m2) 26.3 (0.46) 26.9 (0.49)
University degree (%) 18 (24.3) 20 (26.0)
Employment (%) 61 (83.6) 59 (77.6)
Regular or occasional smoker (%) 13 (18.1) 9 (11.7)
Maximal oxygen consumption (ml/kg/min) 31.7 (0.63) 31.5 (0.54)
Lean muscle mass 40.1 (0.51) 40.2 (0.55)
Use of health-care services in the previous 12 months
Visits to a physician 3.51 (0.42) 3.05 (0.31)
Visits to a nurse (incl. occupational health nurses) 1.04 (0.18) 1.11 (0.15)
Inpatient days 1.23 (0.83) 0.35 (0.12)
Health-related quality of life
SF-36 index score (between 0 and 1) 0.734 (0.0144) 0.730 (0.0121)
doi:10.1371/journal.pone.0135099.t001
Cost-Effectiveness of Physical Activity during Menopause
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improvement in VO2Max, €3,518 per one-gram increase in lean muscle mass, and €1,002 per
QALY gained.
Sensitivity analysis
The first sensitivity analysis applied the assumption that the cost of the aerobic training
instructor’s work contribution would be two times higher per person, which means an increase
in personal time from 3.5 to seven hours in total for the six months of the intervention. The
results were quite similar to those in the main analysis, since additional positive effects of the
physical-activity intervention were achieved at a low price (see Table 3). Neither the results
with equal mobile-phone and heart-monitor costs between the two groups nor the case analysis
carried out showed fundamental differences in comparison to the main analysis (see Table 3).
Discussion
The intervention was cost-effective in terms of cardiorespiratory fitness, lean muscle mass, and
QALYs gained: additional positive effects of physical activity were gained at a very low price
[23]. The findings may point to considerable cost savings to be gained and positive effects on
individuals’ health, functional ability, and work ability, if the higher level of physical activity is
sustained after the intervention.
Menopause may predispose one to a decrease in muscle strength, which can have a negative
effect on ability to work. However, both groups were of average cardiorespiratory fitness for
their age and gender, which is enough for non-work tasks such as shovelling or performing
heavy cleaning. According to Shephard [24], oxygen transport in a sedentary person’s body
Table 2. Direct costs, productivity costs, and costs of intervention.
Intervention group (n = 74) Control group (n = 77)
Unit costa
(EUR)
Number of
units
Mean costa
(EUR)
Number of
units
Mean costa
(EUR)
p-valueb
Direct costs
Visits to a physicianc 104/visit 1.53 159 (20.5) 1.96 203 (26.0) 0.40c
Visits to a nurse (incl. occupational health nurses)c 76/visit 0.44 33 (6.3) 0.44 34 (7.2) 0.75
Medication 48 (31.0) 31 (17.2) 0.56
Inpatient days 785/day 0.02 12 (11.9) 0.10 76 (35.3) 0.12
Productivity costs
Absence from work (€3,470/month) 189/day 4.70 848 (327) 4.84 864 (268) 0.34
Total costs 1,100 (311) 1,208 (279) 0.53
Costs of the intervention
Lectures for both groups 70/hour 11.25 hours 5 11.25 hours 5
Mobile phones (incl. prepaid card) 40 40
Heart-rate monitors 50
Aerobic lessons 27/hour 52 hours 19 -
Supplemental aerobic training instructor’s work
contribution per person
27/hour 3.5 hours 94 -
Total costs 1,307 (311) 1,253 (279) 0.10
a Costs rounded to the nearest euro.
b Mann-Whitney U test.
c Including outpatient-care charge.
doi:10.1371/journal.pone.0135099.t002
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deteriorates by, on average, 5 ml/kg/min per decade and slightly more slowly in vigorously
active persons. In the absence of physical activity, muscle strength decreases by 12–25%
between ages 45 and 65, which may also reduce work ability and increase the likelihood of
early retirement [10]. Moreover, lean muscle mass decreases because of ageing, and the lost
muscle mass is replaced with fatty tissue [1]. As for functional ability, the decreased cardiore-
spiratory fitness, the lower muscle mass, and the higher quantity of fatty tissue may have nega-
tive effect on walking speed in addition to functional ability and work ability. From the
perspective of society, if the positive effects of the intervention described in this paper remain,
women who have physically demanding jobs may be assisted in maintaining their ability to
work, which confers a huge societal advantage because every instance of an avoided disability
pension saves the municipality costs of, on average, €60,000 in Finland [25].
While positive effects of physical activity on cardiorespiratory fitness were seen, increased
fitness levels did not affect the number of days of illness. However, engaging in vigorous-level
physical activity three times a week has been linked to a lower risk of sick leave; moderate phys-
ical activity, meanwhile, had no positive effect on number of days of illness [26]. In addition,
according to a review by Amlani and Munir [27], regular endurance training may reduce sick-
ness-related absence.
From the cost standpoint, the six-month duration of the intervention may have been too
short to highlight effects of physical activity on the level of use of health-care services or the use
Table 3. Mean cost and effect differences (95%CI) between the intervention and control group in the main analysis and the sensitivity analysis,
including incremental cost-effectiveness ratios and cost-effectiveness plane distributions.
Sample size Costs (EUR) Effects ICER Distribution on CE
plane (%)
Intervention
group
Control
group
Δ of intervention—
usual care (95% CI)
Δ of intervention—
usual care (95% CI)
NE SE SW NW
Main analysis
Maximal oxygen
consumption (VO2Max)
74 77 54.0 (-740 to 914) 0.86 (0.15 to 1.60) 62.6 55.2 43.7 0.5 0.6
Lean muscle mass (kg) 74 77 54.0 (-740 to 914) 0.43 (0.01 to 0.83) 125.5 54.4 43.3 0.9 1.4
QALYs 73 77 53.0 (-710 to 930) 1.16 (0.21 to 2.11) 45.9 53.1 46.0 0.2 0.7
Doubled aerobic training
instructors’ costs
Maximal oxygen
consumption
74 77 148 (-647 to 1008) 0.86 (0.15 to 1.60) 171.2 64.0 34.9 0.4 0.6
Lean muscle mass (kg) 74 77 148 (-647 to 1008) 0.43 (0.01 to 0.83) 343.0 63.1 34.6 0.8 1.5
QALYs 73 77 147 (-617 to 1023) 1.16 (0.21 to 2.11) 126.8 61.7 37.5 0.1 0.7
Equal phone and heart-
monitor costs
Maximal oxygen
consumption
74 77 4.02 (-790 to 864) 0.86 (0.15 to 1.60) 4.7 50.1 48.9 0.5 0.5
Lean muscle mass (kg) 74 77 4.02 (-790 to 864) 0.43 (0.01 to 0.83) 9.3 49.5 48.3 1.2 1.2
QALYs 73 77 3.09 (-760 to 880) 1.16 (0.21 to 2.11) 2.7 48.3 50.8 0.3 0.6
Complete case analysis
Maximal oxygen
consumption
56 69 -91.2 (-912 to 813) 0.95 (0.22 to 1.66) -95.8 41.4 58.0 0.3 0.3
Lean muscle mass (kg) 56 69 -91.2 (-912 to 813) 0.43 (-0.01 to 0.88) -213.8 40.3 56.6 1.6 1.5
QALYs 56 69 -91.2 (-912 to 813) 1.22 (0.27 to 2.19) -75.0 41.4 58.1 0.2 0.3
doi:10.1371/journal.pone.0135099.t003
Cost-Effectiveness of Physical Activity during Menopause
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Fig 1. Cost-effectiveness plane for each QALY gained, cardiorespiratory fitness (ml/kg/min), and lean
muscle mass.
doi:10.1371/journal.pone.0135099.g001
Cost-Effectiveness of Physical Activity during Menopause
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Fig 2. Acceptability curve for each QALY gained, cardiorespiratory fitness (ml/kg/min), and lean
muscle mass.
doi:10.1371/journal.pone.0135099.g002
Cost-Effectiveness of Physical Activity during Menopause
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of medication. We have published long-term follow-up results from the present cohort pertain-
ing to work ability [28]. After 2.5 years, participants in the intervention group had higher work
ability, as measured by means of the Work Ability Index, than at the beginning [28]. According
to a previous study [29], physically active people use health-care services less than inactive peo-
ple do. In addition, greater physical activity may help to keep further health-care costs and pro-
ductivity losses under control by preventing symptoms related to menopause. Increased
physical activity may also prevent chronic diseases, such as cardiovascular diseases, which
cause, on average, nine per cent of health-care costs in Europe [30].
Although there are no cost-effectiveness studies related to physical-activity interventions for
menopausal women, recent systematic reviews [31–33] have shown physical activity to be cost-
effective for healthy adults in general. The effectiveness-related results of our study were similar
to findings in previous trials, which showed that at least moderate-intensity walking is one way
to gain health benefits, including improved cardiorespiratory fitness, and a decrease in fat tis-
sue in menopausal women [7, 34]. In addition, it is noteworthy that menopause, with its many
unpleasant symptoms (hot flushes, sleep disorders, night sweats, mood changes, etc.) is a
favourable time at which to increase one’s physical activity in order to ease such symptoms and
enjoy higher quality of life [8, 9, 35, 36]. At the same time, there are findings that contradict
ours: some studies have shown no positive effect of regular physical activity on menopause
symptoms, which may influence quality of life [37–40] or physical activity and might even
increase hot flushes [35]. The connection between physical-activity status and symptoms of
menopause is not simple; for example, obese women (BMI 30) report significantly more
vasomotor and somatic symptoms than do normal-weight or overweight women [38]. Also,
women with lower fitness levels report more hot flushes after moderate-intensity physical
activity than physically active women do [41].
The use of mobile phones in the data collection was a strength of the study, even if the data
received via the phones were not used in the cost-effectiveness analysis. In addition to reporting
hot flushes, participants could contact the researchers, which may have been a motivating fac-
tor and increased adherence to the study. The objectively collected physical-activity-intensity
data (from heart-rate monitor belts) constituted another strength of the study—according to
Prince and colleagues [42], subjectively evaluated levels of physical activity as reported in ques-
tionnaires may involve both over- and under-reporting. However, recall bias may still have
affected the results, with respect to the assessment of health-care utilisation and use of medica-
tion. The shortcomings with the control group involved the reliability of the subjectively col-
lected physical-activity information and the feasibility of the instruction to keep one’s level of
physical activity the same as before the intervention. Also, the study showed deficiencies to do
with the opportunity cost of lost leisure time used for physical activity. In addition, the results
may have been influenced by non-consideration of the travel expenses and time costs related to
the use of health services. Preference weights obtained from a UK population may poorly char-
acterise the results because Finnish people might differ from the UK population in their qual-
ity-of-life preferences. However, the questionnaire used for determination of quality of life has
a greater effect. Sensitivity analyses showed that the main findings on cost-effectiveness were
sustained even after inclusion of only complete cases—i.e., persons with non-missing data.
Symptoms of menopause are quite commonplace in the general ageing population, with
73% of postmenopausal women in Europe reporting hot flushes and almost half (45%) suffer-
ing from sleep disturbances [43]. Therefore, the findings were quite generalisable from this per-
spective. However, severely obese persons (BMI over 35) were excluded from the study
population, which slightly restricts the generalisability of the findings because the worldwide
prevalence of a BMI over 35 is 17.6% [44]. There is a need for more physical-activity trials
aimed at evaluation of cost-effectiveness and for uncovering ways to achieve economic benefit
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via longer work careers, greater work efficiency, and prevention of early retirement and of
chronic diseases alike, all toward the goal of increased HRQoL.
Conclusions
During menopause, the risk of chronic diseases increases, and menopausal women are predis-
posed to a decrease in quality of life, in cardiorespiratory fitness, and in muscle strength and
lean muscle mass. According to our findings, regular physical activity of at least moderate
intensity among menopausal women was cost-effective for cardiorespiratory fitness, lean mus-
cle mass, and gain in QALYs. The intervention may promote ability to work and thereby save
on further costs of early retirement or disability pension. The length of follow-up may have
been too short to reveal any change in use of health-care services or any productivity losses
related to physical activity. More physical-activity trials are necessary for evaluation of cost-
effectiveness on the road to finding ways to gain economic benefit by lengthening work careers,
increasing work efficiency, and preventing early retirement.
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